Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 72,447 | 106,540 | 97,300 | 93,200 | 79,094 |
| Cost of Goods | 6,644 | 21,077 | 7,100 | 9,000 | 8,323 |
| Gross Profit | 65,803 | 85,463 | 90,200 | 84,200 | 70,771 |
| Operating Expenses | 71,358 | 79,254 | 74,500 | 73,400 | 78,138 |
| Operating Income | -4,911 | 6,286 | 15,800 | 10,800 | -7,044 |
| Other Income | 158 | -1,451 | -3,100 | -3,700 | -4,744 |
| Pre-tax Income | -4,753 | 4,835 | 12,700 | 7,100 | -11,788 |
| Income Tax | 459 | -490 | 5,200 | 2,500 | 3,100 |
| Net Income Continuous | -5,212 | 5,325 | 7,500 | 4,600 | -14,888 |
| Minority Interests | N/A | -144 | N/A | N/A | -169 |
| Net Income | $-5,213 | $5,470 | $7,500 | $4,600 | $-14,719 |
| EPS Basic Total Ops | -0.07 | 0.08 | 0.11 | 0.07 | -0.22 |
| EPS Basic Continuous Ops | -0.07 | 0.08 | 0.11 | 0.07 | -0.22 |
| EPS Diluted Total Ops | -0.07 | 0.10 | 0.10 | 0.06 | -0.22 |
| EPS Diluted Continuous Ops | -0.07 | 0.10 | 0.10 | 0.06 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.07 | 0.07 | 0.10 | 0.06 | -0.22 |
| EBITDA(a) | $-1,795 | $9,492 | $18,526 | $13,502 | $-4,462 |